Intended for healthcare professionals


Multidrug resistant TB: fully oral regimens should help improve compliance, says WHO

BMJ 2018; 362 doi: (Published 21 August 2018) Cite this as: BMJ 2018;362:k3610
  1. Declan Murphy
  1. London

Most patients with multidrug resistant tuberculosis (MDR-TB) should be able to get effective treatment from a fully oral drug regimen, the World Health Organization has said.

The agency has issued a rapid communication about treating MDR-TB after evaluating the latest evidence.1 It said that the new advice should inform TB managers and others to start planning towards implementing …

View Full Text

Log in

Log in through your institution


* For online subscription